Mounjaro 15 mg
Tirzepatide
Mounjaro 15mg injection supports weight loss and type 2 diabetes control by regulating insulin, appetite, and blood sugar through hormone-mimicking action.
- Strengths 15mg
- Form Injection
- Packaging Size 2.4ml x 4
- Packaging Type Box
- Manufacturer Eli Lilly
Description of Mounjaro 15 mg
Mounjaro 15mg is a prescription injectable used to manage type 2 diabetes and support weight loss in adults. It contains Tirzepatide, a dual-action incretin mimetic that activates GIP and GLP-1 receptors. This helps improve insulin sensitivity, suppress appetite, and reduce blood sugar levels. Mounjaro 15mg is typically prescribed when lifestyle changes and other medications fail to provide adequate glucose control. Administered once weekly, it should be used under the supervision of a healthcare provider. Mounjaro is not intended for type 1 diabetes or casual weight loss. It works best alongside a balanced diet and regular exercise.
Ingredients of Mounjaro 15 mg
- Tirzepatide 15mg (GIP and GLP-1 receptor agonist)
Usage of Mounjaro 15 mg
- Administer subcutaneously once per week as directed.
- Rotate injection sites weekly to avoid irritation.
- Use with diet and physical activity for best results.
Precautions for Mounjaro 15 mg
- Not recommended for type 1 diabetes.
- Avoid use if allergic to Tirzepatide or with a history of thyroid cancer.
- Consult your doctor before use if pregnant, nursing, or on other medications.
- Monitor blood sugar and report unusual side effects immediately.
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.